Journal of Cancer Survivorship

, Volume 12, Issue 2, pp 186–195 | Cite as

Randomized trial of a clinic-based weight loss intervention in cancer survivors

  • Justin C. Brown
  • Rachel L. Yung
  • Anita Gobbie-Hurder
  • Laura Shockro
  • Keelin O’Connor
  • Nancy Campbell
  • Jocelyn Kasper
  • Erica L. Mayer
  • Sara M. Tolaney
  • Ann H. Partridge
  • Jennifer A. Ligibel
Article
  • 108 Downloads

Abstract

Background

This trial examined the efficacy of a clinic-based weight loss intervention in cancer survivors.

Methods

This single-center phase II trial randomized survivors of solid tumors and hematologic malignancies to a 15-week group-based weight loss intervention that included caloric restriction and physical activity (n = 30) or a wait-list control intervention (n = 30). The primary study outcome was body mass. Secondary study outcomes included body composition using dual-energy X-ray absorptiometry, physical fitness using the 6-min walk test (6MWT), and concentrations of serum biomarkers.

Results

Participants in the intervention group lost 5.6 ± 4.4% of baseline weight (4.6 ± 3.9 kg), whereas participants in the control group gained 0.2 ± 2.4% of baseline weight (0.2 ± 2.0 kg); intervention effect − 5.8% (95% CI − 7.8, − 3.8); − 4.8 kg (95% CI − 6.6, − 3.0); P = 0.0001. A larger proportion of participants in the intervention group lost ≥ 5% of baseline weight compared to the control group (43 vs 0%; P < 0.0001). The intervention led to reductions in fat mass (− 3.2 ± 0.7 kg; P < 0.0001), improvements in physical fitness (an increase of 22.6 ± 10.8 m on 6MWT; P = 0.03), and reductions in concentrations of insulin (− 7.7 ± 3.5 μU/mL; P = 0.004) and leptin (− 7.3 ± 4.0 ng/mL; P = 0.04).

Conclusion

A 15-week clinic-based weight loss intervention resulted in significant weight loss and improvements in body composition, physical fitness, and concentrations of serum biomarkers in cancer survivors.

Implications for cancer survivors

Weight loss programs provide a number of benefits for cancer survivors; survivors should inquire about the availability of lifestyle programs offered at their cancer center and within their local communities.

Keywords

Body composition Body mass index Obesity Insulin Adipokines Inflammation Prognosis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Dana-Farber Cancer Institute and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Greenlee H, Shi Z, Sardo Molmenti CL, Rundle A, Tsai WY. Trends in obesity prevalence in adults with a history of cancer: results from the US National Health Interview Survey, 1997 to 2014. J Clin Oncol. 2016;34(26):3133–40.  https://doi.org/10.1200/JCO.2016.66.4391.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Brown JC, Meyerhardt JA. Obesity and energy balance in GI cancer. J Clin Oncol. 2016;34(35):4217–24.  https://doi.org/10.1200/JCO.2016.66.8699.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Jiralerspong S, Goodwin PJ. Obesity and breast cancer prognosis: evidence, challenges, and opportunities. J Clin Oncol. 2016;34(35):4203–16.  https://doi.org/10.1200/JCO.2016.68.4480.CrossRefPubMedGoogle Scholar
  4. 4.
    Onstad MA, Schmandt RE, KH L. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34(35):4225–30.  https://doi.org/10.1200/JCO.2016.69.4638.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Yang L, Drake BF, Colditz GA. Obesity and other cancers. J Clin Oncol. 2016;34(35):4231–7.  https://doi.org/10.1200/JCO.2016.68.4837.CrossRefPubMedGoogle Scholar
  6. 6.
    Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34(35):4277–83.  https://doi.org/10.1200/JCO.2016.67.9712.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270–6.  https://doi.org/10.1200/JCO.2016.67.4283.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lohmann AE, Goodwin PJ, Chlebowski RT, Pan K, Stambolic V, Dowling RJ. Association of obesity-related metabolic disruptions with cancer risk and outcome. J Clin Oncol. 2016;34(35):4249–55.  https://doi.org/10.1200/JCO.2016.69.6187.CrossRefPubMedGoogle Scholar
  9. 9.
    Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst. 2013;105(18):1344–54.  https://doi.org/10.1093/jnci/djt223.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Goodwin PJ, Segal RJ, Vallis M, Ligibel JA, Pond GR, Robidoux A, et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol. 2014;32(21):2231–9.  https://doi.org/10.1200/JCO.2013.53.1517.CrossRefPubMedGoogle Scholar
  11. 11.
    Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, et al. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. J Clin Oncol. 2015;33(28):3169–76.  https://doi.org/10.1200/JCO.2015.61.1095.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Harrigan M, Cartmel B, Loftfield E, Sanft T, Chagpar AB, Zhou Y, et al. Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the Lifestyle, Exercise, and Nutrition (LEAN) Study. J Clin Oncol. 2016;34(7):669–76.  https://doi.org/10.1200/JCO.2015.61.6375.CrossRefPubMedGoogle Scholar
  13. 13.
    Pakiz B, Flatt SW, Bardwell WA, Rock CL, Mills PJ. Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors. Int J Behav Med. 2011;18(4):333–41.  https://doi.org/10.1007/s12529-010-9079-8.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, et al. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese. Clin Breast Cancer. 2013;13(3):188–95.  https://doi.org/10.1016/j.clbc.2012.12.002.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Phillips SM, Alfano CM, Perna FM, Glasgow RE. Accelerating translation of physical activity and cancer survivorship research into practice: recommendations for a more integrated and collaborative approach. Cancer Epidemiology and Prevention Biomarkers. 2014.Google Scholar
  16. 16.
    Wadden TA, Butryn ML, Hong PS, Tsai AG. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312(17):1779–91.  https://doi.org/10.1001/jama.2014.14173.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation. 2013:01. cir. 0000437739.71477. ee.Google Scholar
  18. 18.
    Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. John Wiley & Sons; 2008.Google Scholar
  19. 19.
    Group DPPR. The diabetes prevention program (DPP). Diabetes Care. 2002;25(12):2165–71.CrossRefGoogle Scholar
  20. 20.
    Enright PL. The six-minute walk test. Respir Care. 2003;48(8):783–5.PubMedGoogle Scholar
  21. 21.
    Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40(1):181–8.  https://doi.org/10.1249/mss.0b013e31815a51b3.CrossRefPubMedGoogle Scholar
  22. 22.
    Hayden-Wade HA, Coleman KJ, Sallis JF, Armstrong C. Validation of the telephone and in-person interview versions of the 7-day PAR. Med Sci Sports Exerc. 2003;35(5):801–9.  https://doi.org/10.1249/01.MSS.0000064941.43869.4E.CrossRefPubMedGoogle Scholar
  23. 23.
    Gibson RS. Principles of nutritional assessment. USA: Oxford university press; 2005.Google Scholar
  24. 24.
    Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. Springer Science & Business Media; 2009.Google Scholar
  25. 25.
    Haggerty AF, Huepenbecker S, Sarwer DB, Spitzer J, Raggio G, Chu CS, et al. The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer. Gynecol Oncol. 2016;140(2):239–44.CrossRefPubMedGoogle Scholar
  26. 26.
    McCarroll ML, Armbruster S, Frasure HE, Gothard MD, Gil KM, Kavanagh MB, et al. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial. Gynecol Oncol. 2014;132(2):397–402.  https://doi.org/10.1016/j.ygyno.2013.12.023.CrossRefPubMedGoogle Scholar
  27. 27.
    Goodwin PJ, Stambolic V. Impact of the obesity epidemic on cancer. Annu Rev Med. 2015;66:281–96.  https://doi.org/10.1146/annurev-med-051613-012328.CrossRefPubMedGoogle Scholar
  28. 28.
    Irwin ML, Cartmel B, Harrigan M, Li F, Sanft T, Shockro L, et al. Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer. 2017;123(7):1249–58.CrossRefPubMedGoogle Scholar
  29. 29.
    Miller CT, Fraser SF, Levinger I, Straznicky NE, Dixon JB, Reynolds J, et al. The effects of exercise training in addition to energy restriction on functional capacities and body composition in obese adults during weight loss: a systematic review. PLoS One. 2013;8(11):e81692.  https://doi.org/10.1371/journal.pone.0081692.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Garcia-Perez I, Posma JM, Gibson R, Chambers ES, Hansen TH, Vestergaard H, et al. Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trial. The Lancet Diabetes & Endocrinology. 2017;5(3):184–95.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Justin C. Brown
    • 1
  • Rachel L. Yung
    • 2
  • Anita Gobbie-Hurder
    • 1
  • Laura Shockro
    • 1
  • Keelin O’Connor
    • 1
  • Nancy Campbell
    • 1
  • Jocelyn Kasper
    • 1
  • Erica L. Mayer
    • 1
  • Sara M. Tolaney
    • 1
  • Ann H. Partridge
    • 1
  • Jennifer A. Ligibel
    • 1
  1. 1.Dana-Farber Cancer InstituteBostonUSA
  2. 2.University of WashingtonSeattleUSA

Personalised recommendations